Abstract
Abstract Background In Israel, the rate of drinking water from desalinated sea water has increased dramatically to 60% in the last two decades. However, desalinated water lacks magnesium. Hypomagnesemia is associated with adverse cardiovascular outcome. Aim To investigate the association of admission serum magnesium levels (sMg) with long-term survival of non-ST-elevation myocardial infarction (NSTEMI) patients in the light of increased use of desalinated sea water. Methods A single-center, retrospective cohort of consecutive petients who were hospitalized with NSTEMI as their primary clinical diagnosis between August 1, 2008 to March 31, 2021. Multivariate Cox regression model was applied for mortality risk. Results Study population included 5,675 NSTEMI patients with a mean age of 71±13 years (range 25 to 110), of whom 3,820 (67%) were males. Mean and median sMg levels were 2.0±0.2 (0.5–6.8), 2.0 mg/dL, respectively. During mean follow-up of 4.1±2.9 years (0–14), 2,238 (39%) patients died. Mortality rate was u-shaped when associated with sMg levels (Figure 1) and the study cohort was divided into quintiles according to the sMg levels (≤1.80; 1.81–1.94; 1.95–2.00; 2.01–2.20; ≥2.21). Patients in the highest compared to the lowest sMg quintiles had significantly higher incidence of renal dysfunction with lower eGRF EPI (62±32 vs 76±26 ml/min/1.73 m2, p<0.001) and lower fasting serum glucose (102±37 vs 115±46 mg/dL, p<0.001). All-cause mortality rate was the highest in the lowest and highest sMg quintiles (48%, 33%, 32%, 33% 54%, respectively, p<0.00). Compared to the 2nd sMg quintile (1.81–1.94 mg/dL), with the lowest mortality risk, the lower sMg quintile was associated with a significant and indpendent 24% increased risk of death in a multivariate model (95% CI 1.07–1.44, p<0.001), while the highest quintile was associated with 48% increased risk (95% CI 1.25–1.74, p<0.01) (Figure 2). Conclusion Admission low sMg is associated with long-term all-cause mortality in NSTEMI patients. Additionally, long-term mortality is also high in NSTEMI patients with renal dysfunction-induced high sMg levels. Funding Acknowledgement Type of funding sources: None.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.